NEFL and myeloid sarcoma: Unlike some biomarkers that exhibit a high degree of specificity to specific pathological processes or diseases, NfL levels can be influenced by various factors beyond MS, including other neurodegenerative conditions, acute neurological insults, and even non-neurological disorders.